Form 4 Filing for WOLF DALE B

This filing details a transaction by WOLF DALE B, a director at AdaptHealth Corp. On June 24, 2026, 18,999 shares of Common Stock were acquired with a transaction price of $0.00, indicated as a settlement of restricted stock units upon vesting. Following this transaction, the post-transaction shares owned are 123,234. Additionally, 14,000 shares of Common Stock are held indirectly by the Dale B. Wolf Generation Skipping Trust, for which WOLF DALE B acts as the investment manager.